VRTX FY 2018 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$125B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3.0B+22.5% YoY

Gross Profit

$2.6B86.6% margin

Operating Income

$635M20.8% margin

Net Income

$2.1B68.8% margin

EPS (Diluted)

$8.09

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.2B

Stock-Based Comp.

$325M

Balance Sheet

Total Assets

$6.2B

Total Liabilities

$1.8B

Stockholders' Equity

$4.4B

Cash & Equivalents

$2.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.0B	$2.5B	+22.5%
Gross Profit	$2.6B	$2.2B	+19.2%
Operating Income	$635M	$123M	+415.4%
Net Income	$2.1B	$263M	+695.8%